Td Private Client Wealth LLC Collegium Pharmaceutical, Inc Transaction History
Td Private Client Wealth LLC
- $4.44 Trillion
- Q3 2025
A detailed history of Td Private Client Wealth LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Td Private Client Wealth LLC holds 2,007 shares of COLL stock, worth $84,896. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,007
Previous 2,007
-0.0%
Holding current value
$84,896
Previous $59.3 Million
18.33%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding COLL
# of Institutions
242Shares Held
36MCall Options Held
52.5KPut Options Held
200-
Black Rock Inc. New York, NY5.79MShares$245 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY3.16MShares$134 Million2.15% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$112 Million1.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.23MShares$94.2 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA1.58MShares$67 Million0.01% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.44B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...